http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112010965-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112010965-B |
| titleOfInvention | Monoclonal antibody aiming at new coronavirus SARS-CoV-2 spinous process protein RBD region and application thereof |
| abstract | The invention discloses a monoclonal antibody aiming at new coronavirus SARS-CoV-2 and its application, the monoclonal antibody is specifically combined with new coronavirus SARS-CoV-2 spinous process protein RBD region; has wide application prospect in preparing SARS-CoV-2 detection products, preparing SARS-CoV-2 antibody inhibiting medicaments and preparing antibody medicament preparations for preventing or treating pneumonia caused by SARS-CoV-2; the monoclonal antibody aiming at the novel coronavirus SARS-CoV-2 has high titer and strong specificity, can be efficiently expressed, can be specifically combined with the spinous process protein RBD region on the surface of the novel coronavirus SARS-CoV-2, can be used for detecting the novel coronavirus, can neutralize and weaken certain toxicity of the novel coronavirus, and plays a role in preventing or/and treating the pneumonia of the novel coronavirus. |
| priorityDate | 2020-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 328.